New triple attack on tough liver cancer shows promise
NCT ID NCT05348811
Summary
This study tested a new three-part treatment for advanced bile duct cancer that cannot be removed by surgery. It combined a targeted chemotherapy delivered directly to the liver, a drug that blocks cancer growth signals, and an immunotherapy drug. The goal was to see if this combination is safe and effective at shrinking tumors and controlling the disease in 25 participants who had not received prior treatment for their advanced cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zhongda Hospital, Southeast University
Nanjing, Jiangsu, 210009, China
Conditions
Explore the condition pages connected to this study.